Oncolytics Biotech Inc.
ONCY
$0.80
-$0.01-1.24%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -38.02M | -33.86M | -29.33M | -26.77M | -23.31M |
| Total Depreciation and Amortization | -38.60K | -35.60K | -32.60K | -35.10K | -25.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.73M | 10.79M | 8.38M | 6.44M | 2.98M |
| Change in Net Operating Assets | -463.10K | 343.90K | 775.90K | 99.90K | 1.39M |
| Cash from Operations | -26.79M | -22.76M | -20.20M | -20.26M | -18.98M |
| Capital Expenditure | -12.00K | -12.00K | -7.00K | -18.20K | -36.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.00K | -12.00K | -7.00K | -18.20K | -36.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 122.20K | 122.20K | 122.20K | 71.40K | 92.40K |
| Issuance of Common Stock | 21.34M | 18.76M | 15.23M | 14.87M | 10.72M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -48.70K | -151.70K | -48.70K | 210.50K | 24.50K |
| Cash from Financing | 20.28M | 17.60M | 14.17M | 14.02M | 10.89M |
| Foreign Exchange rate Adjustments | 530.10K | 629.10K | 770.10K | -421.10K | -757.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.00M | -4.54M | -5.27M | -6.68M | -8.88M |